BOSTON SCIENTIFIC CORPORATION Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase
BOSTON SCIENTIFIC CORPORATION (BSX) had Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase of 3.40% as of 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease · last filed 2020-02-25
- 2019-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase 3.40%.
- 2019-09-30: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase 3.40%.
| Period end | Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase |
|---|---|
| 2019-12-31 | 3.40% 10-K · filed 2020-02-25 |
| 2019-09-30 | 3.40% 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |